Search

everythinglearnresearchcommunity

for

Search:↓

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

The document suggests recognizing "trichiatrists" as doctors specializing in hair and scalp health, using evidence-based treatments.

FUE and SMP together can effectively treat hair loss, needing fewer procedures.

No genetic link between prostaglandins and hair loss found.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hair transplantation is a viable treatment for some types of female hair loss, with careful donor assessment and attention to psychological factors.

The document concludes that hair biology is complex and there are still unanswered questions about hair loss and follicle changes.

Hair loss affects women's self-esteem; treatments like minoxidil can help.

Microneedling is effective for skin rejuvenation and various skin issues, but more research is needed to confirm its safety and effectiveness.

Older women reported negative physical and psychological effects from Botox and facial fillers, feeling neglected by the medical system.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Psychotropic drugs can cause hair loss or excessive hair growth.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

BeauTop improves hair growth in androgenetic alopecia patients.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Body-hair transplant successfully improved scarred areas and frontal hair density without visible chest scarring.

Dermatologists diagnose and manage melanoma more effectively than general practitioners.

The new SFS Scale predicts hair transplant difficulty using hair and skin types, with thick skin and coily hair being hardest to work with.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

High doses of fluconazole can cause reversible hair loss.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.